Found 0 matching trials
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) PHASE1 Patients with Myelodysplastic Syndromes (MDS) often suffer from low platele...
Show More Learn More & Join Trial
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia N/A This study proposes to observe whether a stable platelet count would be mai...
Show More Location
Weill Cornell Medical College/New York Presbyterian Hospital
Learn More & Join Trial
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura NA this study amis to assess the incidence and severity of liver dysfunction i...
Show More Location
Sohag university hospital
Learn More & Join Trial
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. PHASE3 The purpose of this study is to investigate the efficacy, safety and tolera...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures PHASE3 The purpose of this study is to assess the ability of eltrombopag to elevat...
Show More Location
GSK Investigational Site
Learn More & Join Trial
RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag PHASE3 The rationale for this Phase III study is to evaluate the 6 month safety an...
Show More Location
GSK Investigational Site
Learn More & Join Trial
LENS - Long-term Eltrombopag Observational Study N/A A long term observational ocular safety study in adults who have received s...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Bioequivalence Study of Revolade® Eltrombopag 50 mg PHASE4 Status
Active Not Recruiting
Location
Centro de Atención e Investigación Médica
Learn More & Join Trial
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) PHASE2 The goal of this clinical research study is to learn if eltrombopag can hel...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
rhTPO Dose Escalation vs Eltrombopag Switch in ITP NA This study is a prospective, multicenter, randomized controlled study, plan...
Show More Location
Multiple Locations
Learn More & Join Trial